EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the anti-aging effects of fisetin in telomerase-deficient progeria mouse model

Rui Zhao, Haomeng Kou, Duo Jiang, Feng Wang

PeerJ · 12.12.2023 · 11 · e16463

DOI: 10.7717/peerj.16463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 12.12.2023. Verfasst von Rui Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Telomerase, Progeria. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Health Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is a natural and complex process characterized by the gradual deterioration of tissue and physiological functions in the organism over time. Cell senescence, a hallmark of aging, refers to the permanent and irreversible cell cycle arrest of proliferating cells triggered by endogenous stimuli or environmental stresses. Eliminating senescent cells has been shown to extend the healthy lifespan. In this study, we established a progeria mouse model with telomerase deficiency and confirmed the presence of shortened telomere length and increased expression of aging markers p16 INK4a and p21 CIP1 in the organ tissues of G3 Tert -/- mice. We identified fisetin as a potent senolytic drug capable of reversing premature aging signs in telomerase-deficient mice. Fisetin treatment effectively suppressed the upregulation of aging markers p16 INK4a and p21 CIP1 and reduced collagen fiber deposition. Furthermore, we observed a significant elevation in the mRNA level of Stc1 in G3 Tert -/- mice, which was reduced after fisetin treatment. Stc1 has been implicated in anti-apoptotic processes through the upregulation of the Akt signaling pathway. Our findings reveal that fisetin exerts its anti-aging effect by inhibiting the Akt signaling pathway through the suppression of Stc1 expression, leading to the apoptosis of senescent cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseProgeriaAnimalsMiceCyclin-Dependent Kinase Inhibitor p16Proto-Oncogene Proteins c-aktTelomere ShorteningTelomereAgingFlavonols

Stichwörter der Autor:innen

AgingFisetinSenolyticsTelomerase deficient

Substanzen

TelomeraseCyclin-Dependent Kinase Inhibitor p16Proto-Oncogene Proteins c-aktfisetinFlavonols

Autor:innen und Institutionen

  • Department of Genetics, Tianjin Medical University, Tianjin, China.
  • Institute of Prosthodontics School and Hospital of Stomatology, Tianjin Medical University, Tianjin, China.

Förderung

  • National Natural Science Foundation of China
  • Tianjin Health Research Project

Zitieren

APA

Zhao, R., Kou, H., Jiang, D., & Wang, F. (2023). Exploring the anti-aging effects of fisetin in telomerase-deficient progeria mouse model. PeerJ, 11, e16463. https://doi.org/10.7717/peerj.16463

Vancouver

Zhao R, Kou H, Jiang D, Wang F. Exploring the anti-aging effects of fisetin in telomerase-deficient progeria mouse model. PeerJ. 2023;11:e16463. doi:10.7717/peerj.16463

BibTeX
@article{Zhao2023,
  author = {Zhao, Rui and Kou, Haomeng and Jiang, Duo and Wang, Feng},
  title = {Exploring the anti-aging effects of fisetin in telomerase-deficient progeria mouse model},
  journal = {PeerJ},
  year = {2023},
  volume = {11},
  pages = {e16463},
  doi = {10.7717/peerj.16463}
}
Kostenlos starten →